Skip to main content

ADVERTISEMENT

Demetria J. Smith-Graziani, MD, MPH

Demetria Smith-Graziani, MD, MPH, Winship Cancer Institute
Videos
09/03/2024
Demetria Smith-Graziani, MD, MPH, shares insights from the results of the phase 3 INAVO study, evaluating the addition of inavolisib to palbociclib and fulvestrant for patients with PIK3CA-mutated, HR-positive, HER2-negative advanced breast...
Demetria Smith-Graziani, MD, MPH, shares insights from the results of the phase 3 INAVO study, evaluating the addition of inavolisib to palbociclib and fulvestrant for patients with PIK3CA-mutated, HR-positive, HER2-negative advanced breast...
Demetria Smith-Graziani, MD,...
09/03/2024
Oncology